New York Times: The Google co-founder Sergey Brin on Thursday disclosed that he carried a mutation of a gene known as LRRK2 that gave him a higher-than-average risk of contracting Parkinson’s disease.
When I called medical experts and financial analysts for comment, the first question I got was: “Why would he disclose that?”
Read the article for one possible explanation.
No comments:
Post a Comment